Luteolin-7-O-Glucuronide Improves Depression-like and Stress Coping Behaviors in Sleep Deprivation Stress Model by Activation of the BDNF Signaling
Open Access
Abstract
Stress exposure is a major risk factor for mental disorders such as depression. Because of the limitations of classical antidepressants such as side effects, low efficacy, and difficulty in long-term use, new natural medicines and bioactive molecules from plants with greater safety and efficacy have recently attracted attention. Luteolin-7-O-glucuronide (L7Gn), a bioactive molecule present in Perilla frutescens, is known to alleviate severe inflammatory responses and oxidative stress in macrophages. However, its antistress and antidepressant effects have not been elucidated. The present study aims to explore the antidepressant the effect of L7Gn on stress-induced behaviors and the underlying mechanism in a mouse sleep deprivation (SD) model. L7Gn treatment improved depression-like and stress coping behaviors induced by SD stress, as confirmed by the tail suspension test and forced swimming test. Furthermore, L7Gn treatment reduced the blood corticosterone and hippocampal proinflammatory cytokine levels which were increased by SD stress, and L7Gn also increased the mRNA and protein levels of hippocampal brain-derived neurotrophic factor (BDNF) which were reduced by SD stress. Additionally, treatment with L7Gn resulted in increases in the phosphorylation of tropomyosin-related kinase B (TrkB), extracellular signal-regulated kinase (ERK), and cAMP response element-binding protein (CREB), which are downstream molecules of BDNF signaling. These findings suggest that L7Gn have therapeutic potential for SD-induced stress, via activating the BDNF signaling.Keywords
Funding Information
- the Ministry of Science and ICT (MSIT), Re-public of Korea (2020-JDH-2-CG-1)
- the Korean government (MSIT) (NRF2021M3H1A104892211)
This publication has 55 references indexed in Scilit:
- Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain InjuryInternational Journal of Molecular Sciences, 2014
- Antinociceptive, anti-inflammatory and antioxidant activities of aqueous extract from Remirea maritima (Cyperaceae)Journal of Ethnopharmacology, 2013
- Neurotrophin regulation of neural circuit development and functionNature Reviews Neuroscience, 2012
- Brain-Derived Neurotrophic Factor and Neuropsychiatric DisordersPharmacological Reviews, 2012
- The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?Psychoneuroendocrinology, 2011
- Brain‐derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directionsPsychiatry and Clinical Neurosciences, 2010
- Gender differences in the enhanced vulnerability of BDNF+/− mice to mild stressInternational Journal of Neuropsychopharmacology, 2009
- Adverse metabolic and cardiovascular consequences of circadian misalignmentProceedings of the National Academy of Sciences, 2009
- Brain‐derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood‐derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt‐dependent signaling pathwaysJournal of Neuroscience Research, 2008
- Sleep deprivation inhibits adult neurogenesis in the hippocampus by elevating glucocorticoidsProceedings of the National Academy of Sciences, 2006